Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma PlcADS | 1,436,878 | 1,436,878 | 0 | $91.23M | $135.90M | 26.38% | +$44.67M |
| Liquidia Corporation(LQDA) | 8,118,592 | 8,118,892 | +300 | $119.75M | $101.16M | 19.64% | -$18.59M |
| Exelixis, Inc.(EXEL) | 1,525,730 | 1,525,730 | 0 | $56.33M | $67.25M | 13.05% | +$10.92M |
| Agios Pharmaceuticals, Inc.(AGIO) | 701,280 | 1,071,258 | +369,978 | $20.55M | $35.63M | 6.92% | +$15.08M |
| Merus N V | 376,954 | 656,999 | +280,045 | $15.87M | $34.56M | 6.71% | +$18.69M |
| Evolus, Inc.(EOLS) | 2,731,154 | 3,341,970 | +610,816 | $32.86M | $30.78M | 5.98% | -$2.08M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,149,667 | 2,017,352 | -132,315 | $34.14M | $27.29M | 5.30% | -$6.84M |
| Revolution Medicines, Inc.(RVMD) | 465,000 | 636,835 | +171,835 | $16.44M | $23.43M | 4.55% | +$6.99M |
| Anika Therapeutics Inc | 1,435,130 | 1,435,130 | 0 | $21.57M | $15.18M | 2.95% | -$6.39M |
| ABIVAX Société AnonymeADS(ABVX) | 1,269,119 | 1,674,400 | +405,281 | $7.93M | $12.81M | 2.49% | +$4.88M |
| Y-Mabs Therapeutics Inc | 2,342,609 | 2,342,609 | 0 | $10.38M | $10.57M | 2.05% | +$187.4K |
| Rezolute, Inc.(RZLT) | 141,309 | 1,543,014 | +1,401,705 | $409.8K | $6.88M | 1.34% | +$6.47M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 3,107,669 | 638,908 | -2,468,761 | $23.31M | $5.72M | 1.11% | -$17.58M |
| Verrica Pharmaceuticals Inc.(VRCA) | 8,992,954 | 9,239,119 | +246,165 | $3.98M | $4.90M | 0.95% | +$921.0K |
| Tyra Biosciences, Inc.(TYRA) | 25,000 | 189,950 | +164,950 | $232.5K | $1.82M | 0.35% | +$1.59M |
| Aura Biosciences, Inc.(AURA) | 0 | 200,000 | +200,000 | $0 | $1.25M | 0.24% | +$1.25M |
| Sage Therapeutics Inc | 3,052,538 | 0 | -3,052,538 | $24.27M | $0 | — | -$24.27M |